Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cspc Mingfule Pharmaceutical (guangzhou) Co., Ltd.

Clinical trials sponsored by Cspc Mingfule Pharmaceutical (guangzhou) Co., Ltd., explained in plain language.

Trials to join now! 1

Race against time: new drug aims to save brains up to a day after stroke

Disease control Recruiting now

This large Phase 3 trial is testing whether a new clot-dissolving drug (rhTNK-tPA) can help people recover better from a major stroke, even if treatment starts up to 24 hours after symptoms begin. It will enroll about 890 adults who have a blocked brain artery and specific brain …

Phase: PHASE3 • Sponsor: CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC